CHINA PHARMA HOLDINGS, INC. - CPHI

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q2 2026 · Compare: Q1 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
CITADEL ADVISORS LLC History Added to 125,445 82 0.0% 0.0% 1 +112,521 870.64% Q2 2026 Sep 02, 2026
TWO SIGMA SECURITIES, LLC History New 35,666 23 0.0% — 2 +35,666 New Q2 2026 Aug 14, 2026
JANE STREET GROUP, LLC History New 13,886 9 0.0% — 4 +13,886 New Q2 2026 Aug 14, 2026
RENAISSANCE TECHNOLOGIES LLC History Added to 15,045 9 0.0% 0.0% 3 +3,627 31.77% Q2 2026 Aug 13, 2026
Ground Swell Capital, LLC History New 10,610 7 0.01% — 5 +10,610 New Q2 2026 Aug 05, 2026
UBS Group AG History Added to 3,109 2 0.0% — 6 +2,720 699.23% Q2 2026 Aug 13, 2026
CITIGROUP INC History Closed out 0 0 — — — -996 -100.0% Q2 2026 Aug 03, 2026
DANSKE BANK A/S History No change 1 0 — — — 0 0.0% Q2 2026 Aug 10, 2026
EFG International AG History No change 40 0 — — — 0 0.0% Q2 2026 Aug 14, 2026